abstract |
The subject of the invention is a purified polypeptide, designated ULIP6, comprising an amino acid sequence SEQ ID ndegre 2, the nucleic acid coding for this polypeptide, a non-coding sequence 3 ′ of this coding sequence and their use in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes. |